For session
MTC 02
Cervical cancer control in high income countries- current standards and challenges
Cytology has been for a long time the primary screening tool in cervical cancer screening programmes. The recognition that the sensitivity for cervical (pre)cancer of an HPV test is much higher than the sensitivity of cytomorphological investigation of a cervical smear and that an objective HPV test is more easy to implement than a subjective cytology test has led to the introduction of HPV testing as primary screening tool in cervical screening programmes. Introduction of an HPV test in population based screening raises questions about “which HPV test and which triage test should be used?, which screening intervals should be advised?, should we use self-collected cervico/vaginal material? and how should we follow up women who have been vaccinated. Although recently guidelines for HPV based screening have been developed questions about a number of the above mentioned issues still remain. Of course the burden of the disease , local setting and the resources available in different countries determine the screening strategy that will be implemented. One way to limit the growing national HPV based screening strategies is to define minimum requirements in terms of efficacy and safety of the screening programme in relation to the burden of investigations for women participating in the programme but do not have cervical (pre)cancer. In the presentation these issues are further highlighted.
For session
MTC 02
Cervical cancer control in high income countries- current standards and challenges
For session
MTC 02
Cervical cancer control in high income countries- current standards and challenges